Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis
Biological and Pharmaceutical Bulletin · 2026
DOI: 10.1248/bpb.b26-00440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2026. Verfasst von Borui Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer and Senescence Biology, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan. Hauptthemen laut MEDLINE: Fibroblasts, Melanoma, Cyclin-Dependent Kinase Inhibitor p16, Extracellular Matrix Proteins. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
The tumor microenvironment contains phenotypically diverse stromal cells that can support tumor progression; however, the identity and function of stromal populations expressing the senescence marker p16Ink4a in melanoma remain poorly defined. We combined p16-CreERT2-tdTomato lineage tracing with single-cell RNA sequencing in a syngeneic YUMMER1.7-H2B-GFP5 melanoma model to characterize p16Ink4a-lineage-positive [p16-Lin(+)] stromal cells and identify candidate mediators of tumor-stroma interactions. Immunofluorescence detected p16-Lin(+) cells across multiple stromal populations, while transcriptomic analysis identified fibroblasts as a major p16-Lin(+) stromal population. The integration of differentially expressed genes in p16-Lin(+) fibroblasts with a secretome database and survival data from The Cancer Genome Atlas Skin Cutaneous Melanoma cohort identified spondin 1 (SPON1) as a candidate extracellular mediator. Spon1 was preferentially expressed in fibroblasts, upregulated in the p16-Lin(+) fraction, and nearly undetectable in YUMMER1.7-H2B-GFP5 cells. Immobilized recombinant SPON1 promoted YUMM1.7 cell proliferation in a dose-dependent manner in vitro. In an independent human skin tumor single-cell dataset, SPON1 expression was enriched in fibroblasts, with higher enrichment observed in those expressing CDKN2A, which encodes p16INK4A. Moreover, high SPON1 expression was independently associated with shorter overall survival after adjusting for tumor type, age, and sex. Together, these findings identify SPON1 as a candidate factor enriched in p16-Lin(+) fibroblasts, with potential functional and prognostic relevance in melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer and Senescence Biology, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
- Integrated Systems of Aging Research Unit, Institute for Frontier Science Initiative, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan.
Zitieren
APA
Li, B., Kumamoto, S., Nakano, Y., & Johmura, Y. (2026). Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b26-00440
Vancouver
Li B, Kumamoto S, Nakano Y, Johmura Y. Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis. Biological and Pharmaceutical Bulletin. 2026. doi:10.1248/bpb.b26-00440
BibTeX
@article{Li2026,
author = {Li, Borui and Kumamoto, Soichiro and Nakano, Yasuhiro and Johmura, Yoshikazu},
title = {Spondin 1 Enriched in p16Ink4a Reporter-Labeled Fibroblasts Promotes Melanoma Cell Proliferation in Vitro and Is Associated with Poor Prognosis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
doi = {10.1248/bpb.b26-00440}
}
EUVIMED